Invention Grant
- Patent Title: Anti-viral compounds
-
Application No.: US15588037Application Date: 2017-05-05
-
Publication No.: US10053474B2Publication Date: 2018-08-21
- Inventor: Jaclyn Chau , Hui-Ju J. Chen , David A. DeGoey , John Hartung , Nathan Ide , Vikram Kalthod , Allan C. Krueger , Yi-Yin Ku , Tongmei Li , John T. Randolph , Rolf Wagner , Geoff T. Halvorsen , Christopher C. Marvin , Eric Voight , Brian S. Brown , Steven R. Martinez , Anurupa Shrestha , Howard R. Heyman
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: A61K31/675
- IPC: A61K31/675 ; C07F9/02 ; C07F9/08 ; C07F9/6512 ; C07H19/10
Abstract:
The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Public/Granted literature
- US20180022763A1 Anti-Viral Compounds Public/Granted day:2018-01-25
Information query
